No Data
No Data
Rakovina Therapeutics Raises $2 Million in Oversubscribed Private Placement
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
Stocks in Play: Rakovina Therapeutics Inc.